<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>iyu · AI, explained</title>
    <link>https://iyu.app/</link>
    <atom:link href="https://iyu.app/feed.xml" rel="self" type="application/rss+xml"/>
    <description>Scouting the AI frontier and explaining it in plain language — sources checked, no fluff.</description>
    <language>en</language>
    <item>
      <title>Tencent's China Games Power Q2 Growth</title>
      <link>https://iyu.app/e/tencent-q2-2026-games-growth</link>
      <guid>https://iyu.app/e/tencent-q2-2026-games-growth</guid>
      <pubDate>Wed, 12 Aug 2026 09:00:00 +0000</pubDate>
      <description>Tencent reported RMB204.8 billion in second-quarter revenue, up 11% year on year, with domestic games delivering the clearest acceleration. International games showed a split result: down 0.8% as reported but up 4% after holding exchange rates constant.</description>
    </item>
    <item>
      <title>Phantom Blade Zero Opens Pre-Orders</title>
      <link>https://iyu.app/e/phantom-blade-zero-preorders-state-of-play</link>
      <guid>https://iyu.app/e/phantom-blade-zero-preorders-state-of-play</guid>
      <pubDate>Wed, 12 Aug 2026 09:00:00 +0000</pubDate>
      <description>Phantom Blade Zero is available to pre-order ahead of its October 29 launch on PS5 and PC. A standalone State of Play will show nearly 20 minutes of gameplay, while PS5 pre-orders offer two progression-earnable items as early unlocks rather than exclusives.</description>
    </item>
    <item>
      <title>Claude Adds Machine-Readable Marks</title>
      <link>https://iyu.app/e/claude-text-watermark-eu-transparency</link>
      <guid>https://iyu.app/e/claude-text-watermark-eu-transparency</guid>
      <pubDate>Wed, 12 Aug 2026 09:00:00 +0000</pubDate>
      <description>Anthropic is introducing two machine-readable signals: an imperceptible watermark woven into generated text and C2PA provenance metadata for supported files. The marks can aid detection, but neither a positive nor a negative result settles authorship on its own.</description>
    </item>
    <item>
      <title>High-Dose Vitamin D Misses Cancer Trial Goal</title>
      <link>https://iyu.app/e/solaris-high-dose-vitamin-d-colorectal-cancer</link>
      <guid>https://iyu.app/e/solaris-high-dose-vitamin-d-colorectal-cancer</guid>
      <pubDate>Wed, 12 Aug 2026 09:00:00 +0000</pubDate>
      <description>A larger randomized trial did not confirm the progression-free survival signal seen in an earlier phase 2 study. The result applies to high- versus standard-dose vitamin D added to a specific first-line regimen, not to vitamin D deficiency care in general.</description>
    </item>
    <item>
      <title>Midlife Fitness Tracks With Healthier Aging</title>
      <link>https://iyu.app/e/midlife-fitness-healthy-aging-cohort</link>
      <guid>https://iyu.app/e/midlife-fitness-healthy-aging-cohort</guid>
      <pubDate>Wed, 12 Aug 2026 09:00:00 +0000</pubDate>
      <description>Higher midlife cardiorespiratory fitness was associated with a modestly longer healthspan and lifespan in a long US cohort. Selection, measurement and observational limits matter before treating the estimates as an exercise prescription.</description>
    </item>
    <item>
      <title>Free ChatGPT Plus Year Is Not Official Yet</title>
      <link>https://iyu.app/e/openai-free-chatgpt-plus-year-us-students</link>
      <guid>https://iyu.app/e/openai-free-chatgpt-plus-year-us-students</guid>
      <pubDate>Wed, 12 Aug 2026 09:00:00 +0000</pubDate>
      <description>A reported back-to-school campaign could give eligible US college students ChatGPT Plus for a year. The practical move is to wait for OpenAI's official terms before paying for a long subscription.</description>
    </item>
    <item>
      <title>Manus Splits From Meta: Back Up Now</title>
      <link>https://iyu.app/e/manus-meta-separation-data-backup</link>
      <guid>https://iyu.app/e/manus-meta-separation-data-backup</guid>
      <pubDate>Tue, 11 Aug 2026 09:00:00 +0000</pubDate>
      <description>Manus is separating from Meta and says regulatory requirements will force deletion of certain affected users’ post-acquisition data. The company has opened backup tools now, with restoration beginning August 25, but it has not publicly named the affected jurisdictions in its notice.</description>
    </item>
    <item>
      <title>AI can audit papers, but not judge alone</title>
      <link>https://iyu.app/e/ai-agents-scientific-error-checking</link>
      <guid>https://iyu.app/e/ai-agents-scientific-error-checking</guid>
      <pubDate>Tue, 11 Aug 2026 09:00:00 +0000</pubDate>
      <description>Nature reports that AI tools have uncovered old chemistry-data errors and scanned research papers at scale. The underlying preprints also show unstable recall, false positives and a crucial gap between rerunning claims and proving a paper wrong.</description>
    </item>
    <item>
      <title>Fructose linked to ovarian cancer spread in mice</title>
      <link>https://iyu.app/e/fructose-sasp-ovarian-cancer-dissemination</link>
      <guid>https://iyu.app/e/fructose-sasp-ovarian-cancer-dissemination</guid>
      <pubDate>Tue, 11 Aug 2026 09:00:00 +0000</pubDate>
      <description>Cell and mouse experiments connect a chemotherapy-induced senescent secretome to fructose, lower membrane cholesterol, easier tumor-cell detachment and greater ovarian-cancer dissemination. The work is mechanistic and preclinical, not dietary guidance.</description>
    </item>
    <item>
      <title>FMT hints at a peanut-allergy pathway</title>
      <link>https://iyu.app/e/fmt-peanut-allergy-bile-acid-phase-1</link>
      <guid>https://iyu.app/e/fmt-peanut-allergy-bile-acid-phase-1</guid>
      <pubDate>Mon, 10 Aug 2026 09:00:00 +0000</pubDate>
      <description>An open-label phase 1 trial tested oral encapsulated fecal microbiota transplantation in 15 adults with peanut allergy. Six showed higher challenge thresholds, but the tiny uncontrolled study is a safety and mechanism signal, not evidence for routine treatment.</description>
    </item>
  </channel>
</rss>
